The Impact of Residual Symptoms in Major Depression

被引:57
作者
Israel, Joshua A. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco VA Med Ctr, 4150 Clement St,116N, San Francisco, CA 94121 USA
关键词
major depressive disorder; MDD; antidepressive agents; residual symptoms; depression; depression treatment;
D O I
10.3390/ph3082426
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The current definition of remission from major depressive disorder does not fully take into account all aspects of patient recovery. Residual symptoms of depression are very common in patients who are classified as being in remission. Patients with residual symptoms are at increased risk of functional and interpersonal impairments, and are at high risk for recurrence of depression. This article discusses the incidence of residual symptoms of depression, as well as the risks and consequences of these symptoms, and will review the state of current treatment.
引用
收藏
页码:2426 / 2440
页数:15
相关论文
共 89 条
[1]   Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study [J].
Andreescu, Carmen ;
Lenze, Eric J. ;
Dew, Mary Amanda ;
Begley, Amy E. ;
Mulsant, Benoit H. ;
Dombrovski, Alexandre Y. ;
Pollock, Bruce G. ;
Stack, Jacqueline ;
Miller, Mark D. ;
Reynolds, Charles F. .
BRITISH JOURNAL OF PSYCHIATRY, 2007, 190 :344-349
[2]   Mixed anxiety-depression and its implications far models of mood and anxiety disorders [J].
Barlow, DH ;
Campbell, LA .
COMPREHENSIVE PSYCHIATRY, 2000, 41 (02) :55-60
[3]   Lithium augmentation in treatment-resistant-depression:: Meta-analysis of placebo-controlled studies [J].
Bauer, M ;
Döpfmer, S .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) :427-434
[4]  
Belmaker R. H., 2007, NEW ENGL J MED, V358, P55
[5]  
Bernert R. A., 2007, NEUROPSYCH DIS TREAT, V3, P737
[6]   Residual symptoms of depression: clinical and theoretical implications [J].
Boulenger, JP .
EUROPEAN PSYCHIATRY, 2004, 19 (04) :209-213
[7]   A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder [J].
Carney, Colleen E. ;
Segal, Zindel V. ;
Edinger, Jack D. ;
Krystal, Andrew D. .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) :254-260
[8]   Neurostimutation in resistant depression [J].
Carpenter, Linda L. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (03) :35-40
[9]   A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine [J].
Carpenter, LL ;
Yasmin, S ;
Price, LH .
BIOLOGICAL PSYCHIATRY, 2002, 51 (02) :183-188
[10]   Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice [J].
Cuffel, BJ ;
Azocar, F ;
Tomlin, M ;
Greenfield, SF ;
Busch, AB ;
Croghan, TW .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (04) :397-402